HIMS Form 144 plans 2,637-share sale; Fidelity as broker

Rhea-AI Filing Summary

Hims & Hers Health (HIMS) filed a Form 144 notice for the proposed sale of up to 2,637 shares of its Class A common stock. The filing lists an aggregate market value of $132,113.70, an approximate sale date of 10/27/2025, execution through Fidelity Brokerage Services LLC, and the listing on the NYSE.

The shares were acquired on 09/15/2025 via restricted stock vesting as compensation, in the same amount of 2,637 shares. Recent activity by the same seller shows additional open-market transactions in the past three months, including 2,572 shares on 07/28/2025 for $150,976.40 and 2,637 shares on 09/29/2025 for $155,029.23.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2637	132113.70	217641958	10/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/15/2025	Restricted Stock Vesting	Issuer			2637	09/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/28/2025	2572	150976.40
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	08/11/2025	2572	132818.08
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	08/25/2025	2571	114486.63
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	09/17/2025	2637	133168.50
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	09/29/2025	2637	155029.23
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	10/13/2025	2637	143400.06

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did HIMS disclose in this Form 144?

A proposed sale of up to 2,637 Class A shares with an aggregate market value of $132,113.70.

When is the approximate sale date for the HIMS shares?

The filing lists an approximate sale date of 10/27/2025.

How were the shares to be sold acquired?

They were acquired on 09/15/2025 through restricted stock vesting as compensation, totaling 2,637 shares.

Which broker is named for the proposed sale?

The broker listed is Fidelity Brokerage Services LLC.

On which exchange are the shares listed?

The shares are listed on the NYSE.

Were there recent sales by the same seller?

Yes. Examples include 2,572 shares on 07/28/2025 for $150,976.40 and 2,637 shares on 09/29/2025 for $155,029.23.